LemmerBNoldG. Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol1991; 32: 627–9.
2.
DaneshmendTKJacksonLRobertsCJC. Physiological and pharmacological variability in estimated hepatic blood flow in man. Br J Clin Pharmacol1981; 11: 491–6.
3.
SvenssonCKEdwardsDJMaurielloPMBardeSHFosterACLancRAEffect of food on hepatic blood flow: Implications in the food effect phenomenon. Clin Pharmacol Ther1983; 34: 316–23.
4.
OlanoffLSWalleTCowartTDWalleUKOexmannMJConradiEC. Food effects on propranolol systemic and oral clearance. Support for a blood flow hypothesis. Clin Pharmacol Ther1986; 40: 408–14.
5.
LangnerBLemmerB. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol1988; 33: 619–24.
6.
LemmerBScheidelBBehneS. Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs: Propranolol, organic nitrates, nifedipine. Ann N Y Acad Sci1991; 618: 166–81.
7.
De MeyCMeinekeI. Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA). Br J Clin Pharmacol1992; 33: 179–82.
8.
HrusheskyWJM. Circadian timing of cancer chemotherapy. Science1985; 228: 73–6.
9.
RivardGEHoyouxCInfant-RivardCChampagneJ. Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: Better in the evening?Lancet1985; 2: 1264–6.
10.
LangevinAMKorenGSoldinSJGreenbergMA. Pharmacokinetic case for giving 6-mercaptopurine maintenance dose at night. Lancet1987; 2: 505–6.
11.
FerrazziniGSohlHRobieuxIJohnsonEGiesbrechtEKorenG. Diurnal variation of methotrexate disposition in children with acute leukaemia. Eur J Clin Pharmacol1991; 41: 425–7.
12.
DamascelliBMarchianoASpreaficoCLutmanRSalvettiMBonalumiMGCircadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump. Cancer1990; 66: 237–41.
RosenthalE. Doctors time to body rhythms. New York Times1990 Oct 2;Sect. B:5.
15.
MullerJEToflerGH. Circadian variations and cardiovascular disease. N Engl J Med1991; 325: 1038–9.
16.
PanzaJAEpsteinSEQuyyumiAA. Circadian variation in vascular tone and its relation to α-sympathetic vasoconstrictor activity. N Engl J Med1991; 325: 986–90.
17.
MullerJEToflerGHStonePH. Circadian variation and triggers of onset of acute cardiovascular events. Circulation1989; 79: 733–43.
18.
LoiCMVestalRE. Drug metabolism in the elderly. Pharmacol Ther1988; 36: 131–49.
19.
VestalREWoodAJJShandDG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther1979; 26: 181–6.
20.
SilberBHolfordNHGRiegelmanS. Stereoselective disposition and glucuronidation of propranolol in humans. J Pharm Sci1982; 71: 699–704.
21.
MurrayKTReillyCKoshakjiCRodenRPLineberryMDWoodAJJSuppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockage. J Clin Invest1990; 85: 836–42.
HooperWDQingMS. The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans. Clin Pharmacol Ther1990; 48: 633–40.
24.
ZhouHHWhelanEWoodAJJ. Lack of effect of ageing on the stereochemical disposition of propranolol. Br J Clin Pharmacol1992; 33: 121–3.
25.
MontamatCCusakBJVestalRE. Management of drug therapy in the elderly. N Engl J Med1989; 321: 303–9.
26.
DreyfussDShaderRIHarmatzJSGreenblattDJ. Kinetics and dynamics of single doses of oxazepam in the elderly: Implications of absorption rate. J Clin Psychiatry1986; 47: 511–4.
27.
GreenblattDJDivollMHarmatzJSShaderRI. Oxazepam kinetics: Effects of age and sex. J Pharmacol Exp Ther1980; 215: 86–91.
28.
SonneJLoftSDossingMBoesgaardSAndreasenF. Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalized subjects. Br J Clin Pharmacol1991; 31: 719–22.
29.
SchmuckerDLWoodhouseKWWangRKWynneHJamesOFMcManusMEffects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther1990; 48: 365–74.
30.
HerdBWynneHWrightPJamesOWoodhouseK. The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions. Br J Clin Pharmacol1991; 32: 768–70.
31.
WynneHACopeLHHerdBMRawlinsMDJamesOFWWoodhouseKW. The association of age and frailty with paracetamol conjugation in man. Age Ageing1990; 19: 419–24.
32.
PouwelsMJMHooymansPMvan der AaGCGribnauFW. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly. Ann Pharmacother1991; 25: 1043–6.
33.
JohnsonBFLaderS. Bioavailability of digoxin from rapidly dissolving preparations. Br J Clin Pharmacol1974; 1: 329–33.
34.
O'GradyJJohnsonBFByeCFrenchJ. The comparative bioavailability of Lanoxin tablets and Lanoxicaps. Eur J Clin Pharmacol1987; 14: 357–60.
